Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Published in: Current Atherosclerosis Reports 3/2015

01-03-2015 | Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Radial Artery Occlusion After Transradial Approach to Cardiac Catheterization

Authors: John F. Wagener, Sunil V. Rao

Published in: Current Atherosclerosis Reports | Issue 3/2015

Login to get access

Abstract

Radial artery occlusion (RAO) is the most common complication of the transradial approach (TRA) to cardiac catheterization, with a reported incidence between 0.8 % and 30 %. RAO is likely the result of acute thrombus formation and complicated by neointimal hyperplasia. Most RAO are asymptomatic with rare cases of acute hand or digit ischemia reported in the literature. The role of testing for dual circulation to the hand in determining the safety of TRA as it relates to symptomatic RAO is controversial; however, modifiable risk factors like low sheath-to-artery ratio, adequate anticoagulation, and non-occlusive (“patent”) hemostasis are likely to prevent RAO. This review examines the incidence of RAO, potential mechanisms leading to RAO, and strategies to prevent and treat RAO.
Literature
1.•
Feldman DN, Swaminathan RV, Kaltenbach LA, et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: An updated report from the national cardiovascular data registry (2007-2012). Circulation. 2013;127:2295–306.CrossRefPubMed
2.
Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol. 2003;92:930–5.CrossRefPubMed
3.
Rao SV, O’Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96:1200–6.CrossRefPubMed
4.
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774–82.CrossRefPubMed
5.
Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol. 2007;49:1362–8.CrossRefPubMed
6.
Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systemic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132–40.CrossRefPubMed
7.
Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomized, parallel group, multicenter trial. Lancet. 2011;377:1409–20.CrossRefPubMed
8.•
Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in st-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9.CrossRefPubMed
9.
Cooper CJ, El-Shiekh RA, Cohen DJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J. 1999;138:430–6.CrossRefPubMed
10.
Caputo RP, Tremmel JA, Rao S, et al. Transradial arterial access for coronary and peripheral procedures: Executive summary by the Transradial Committee of the SCAI. Catheter Cardiovasc Interv. 2011;78:823–39.CrossRefPubMed
11.•
Shroff A, Siddiqui S, Burg A, Singla I. Identification and Management of Complications of Transradial Procedures. Curr Cardiol Rep. 2013;15:350–8.CrossRefPubMed
12.•
Uhlemann M, Mobius-Winkler S, Mende M, Eitel I, Fuernau G, Sandri M, et al. The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization: Impact of Sheath Size on Vascular Complications. J Am Coll Cardiol Intv. 2012;5:36–43.CrossRef
13.
Nagai S, Abe S, Sato T, Hozawa K, Yuki K, Hanashima K, et al. Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach. Am J Cardiol. 1999;83:180–6.CrossRefPubMed
14.
Sanmartin M, Gomez M, Rumoroso JR, Sadaba M, Martinez M, Baz JA, et al. Interruption of blood flow during compression and radial artery occlusion after transradial catheterization. Catheter Cardiovasc Interv. 2007;70:185–9.CrossRefPubMed
15.
Zankl AR, Andrassy M, Volz C, Ivandic B, Krumsdorf U, Katus HA, et al. Radial artery thrombosis following transradial coronary angiography: incidence and rational for treatment of symptomatic patients with low-molecular-weight-heparins. Clin Res Cardiol. 2010;99:841–7.CrossRefPubMed
16.•
Buturak A, Gorgulu S, Norgaz T, et al. The long term incidence and predictors of radial artery occlusion following a transradial coronary procedure. Cardiol J. 2014; March 27th online publication. Pages 1-12.
17.•
Kotowycz MA, Dzavik V. Radial Artery Patency After Transradial Catheterization. Circ Cardiovasc Interv. 2012;5:127–33.CrossRefPubMed
18.
Yonetsu T, Kakuta T, Lee T, et al. Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography. Eur Heart J. 2010;31:1608–15.CrossRefPubMed
19.
Saito S, Ikei H, Hosokawa G, Tanaka S. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Catheter Cardiovasc Interv. 1999;46:173–8.CrossRefPubMed
20.
Yoo BS, Yoon J, Ko JY, Kim JY, Lee SH, Hwang SO, et al. Anatomical consideration of the radial artery for transradial coronary procedures: arterial diameter, branching anomaly and vessel tortuosity. Int J Cardiol. 2005;101:421–7.CrossRefPubMed
21.
Kim KS, Park HS, Jang WI, Park JH. Thrombotic occlusion of the radial artery as a complication of the transradial coronary intervention. J Cardiovasc Ultrasound. 2010;18:31.CrossRefPubMedCentralPubMed
22.
Babunashvili A, Dundua D. Recanalization and reuse of early occluded radial artery within 6 days after previous transradial diagnostic procedure. Catheter Cardiovasc Interv. 2011;77:530–6.CrossRefPubMed
23.
Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME. Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med. 1986;164(4):1171–8.CrossRefPubMed
24.
Wakeyama T, Ogawa H, Iida H, Takaki A, Iwami T, Mochizuki M, et al. Intima-media thickening of the radial artery after transradial intervention: an intravascular ultrasound study. J Am Coll Cardiol. 2003;41:1109–14.CrossRefPubMed
25.
Edmundson A, Mann T. Nonocclusive radial artery injury resulting from transradial coronary interventions: radial artery IVUS. J Invasive Cardiol. 2005;17:528–31.PubMed
26.
Staniloae CS, Mody KP, Sanghvi K, Mindrescu C, Coppola JT, Antonescu CR, et al. Histopathologic changes of the radial artery wall secondary to transradial catheterization. Vasc Health Risk Manag. 2009;5:527–32.PubMedCentralPubMed
27.
Sakai H, Ikeda S, Harada T, Yonashiro S, Ozumi K, Ohe H, et al. Limitations of successive transradial approach in the same arm: the Japanese experience. Catheter Cardiovasc Interv. 2001;54:204–8.CrossRefPubMed
28.
Kamiya H, Ushijima T, Kanamori T, Ikeda C, Nakagaki C, Ueyama K, et al. Use of the radial artery graft after transradial catheterization: is it suitable as a bypass conduit? Ann Thorac Surg. 2003;76:1505–9.CrossRefPubMed
29.•
Beyer AT, Ng R, Singh A, Zimmet J, Shunk K, Yeghiazarians Y, et al. Topical nitroglycerin and lidocaine to dilate the radial artery prior to transradial cardiac catheterization: A randomized, placebo-controlled, double-blind clinical trial The PRE-DILATE Study. Int J Cardiol. 2013;168:2575–8.CrossRefPubMed
30.••
Dharma S, Kedev S, Patel T, Kiemeneij F, Gilchrist IC. A novel approach to reduce radial artery occlusion after trans-radial catheterization: post-procedural/pre-hemostasis intra-arterial nitroglycerin. Catheter Cardiovasc Interv. 2014;Sep 1. Ahead of Print.
31.•
Pancholy SB, Bertrand OF, Patel T. Comparison of A Priori Versus Provisional Heparin Therapy on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis (from the PHARAOH Study). Am J Cardiol. 2012;110:173–6.CrossRefPubMed
32.
Stella PR, Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. Incidence and Outcome of Radial Artery Occlusion Following Transradial Artery Coronary Angiography. Cathet Cardiovasc Diagn. 1997;40:156–8.CrossRefPubMed
33.•
Dandekar VK, Vidovich MI, Shroff AR. Complications of transradial catheterization. Cardiovasc Revasc Med. 2012;13:39–50.CrossRefPubMed
34.
Shroff A, Siddiqui S, Burg A, Singla I. Identification and Management of Complications of Transradial Procedures. Curr Cardiol Rep. 2013;15:350–8.CrossRefPubMed
35.
Rhyne D, Mann T. Hand ischemia resulting from a transradial intervention: successful management with radial artery angioplasty. Catheter Cardiovasc Interv. 2010;76:383–6.CrossRefPubMed
36.
Ruzsa Z, Pinter L, Kolvenbach R. Anterograde recanalization of the radial artery followed by transradial angioplasty. Cardiovasc Revasc Med. 2010;11(266):e261–4.
37.•
Rao SV. Our Remedies Oft in Ourselves Do Lie. J Am Coll Cardiol Intv. 2012;5(1):44–6.CrossRef
38.
Greenwood MJ, Della-Siega AJ, Fretz EB, Kinloch D, Klinke P, Mildenberger R, et al. Vascular communications of the hand in patients being considered for transradial coronary angioplasty; is the Allen’s test accurate? J Am Coll Cardiol. 2005;46:2013–7.CrossRefPubMed
39.
Fuhrman TM, Pippin WD, Talmage LA, Reilley TE. Evaluation of collateral circulation of the hand. J Clin Monit. 1992;8(1):28–32.CrossRefPubMed
40.
Starnes SL, Wolk SW, Lampman RM, Shanley CJ, Proger RL, Kong BK, et al. Noninvasive evaluation of hand circulation before radial artery harvest for coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1999;117:261–6.CrossRefPubMed
41.
Jarvis MA, Jarvis CL, Jones PR, Spyt TJ. Reliability of Allen’s test in selection of patients for radial artery harvest. Ann Thorac Surg. 2000;70:1362–5.CrossRefPubMed
42.
Barbeau GR, Arsenault F, Dugas L, Simard S, Lariviere MM. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: Comparison with the Allen’s test in 1010 patients. Am Heart J. 2004;147:489–93.CrossRefPubMed
43.•
Valgimigli M, Camp G, Penzo C, Tebaldi M, Biscaglia S, Ferrari R. Transradial Coronary Catheterization and Intervention Across the Whole Spectrum of Allen Test Results. J Am Coll Cardiol. 2014;63:1833–41.CrossRefPubMed
44.
Sueda S, Mineoi K, Ochi T, Ochi N, Kukita H, Kawada H, et al. Size of radial artery in Japanese patients: an angiographic study [in Japanese]. Jpn J Interv Cardiol. 1997;12:29–33.
45.
Dahm JB, Vogelgesang D, Hummel A, Staudt A, Volzke H, Felix SB. A randomized trial of 5 vs 6 French transradial percutaneous coronary interventions. Catheter Cardiovasc Interv. 2002;57:172–6.CrossRefPubMed
46.•
Takeshita S, Asano H, Hata T. and the NAUSICA Trail Investigators. Comparison of Frequency of Radial Artery Occlusion After 4Fr Versus 6Fr Transradial Coronary Intervention (from the Novel Angioplasty USIng Coronary Accessor Trial). Am J Cardiol. 2014;113:1986–9.CrossRefPubMed
47.•
Chugh SK, Chugh S, Chugh Y, Rao SV. Feasibility and utility of pre-procedural ultrasound imaging of the arm to facilitate transradial coronary diagnostic and interventional procedures (PRIMAFACIE-TRI). Catheter Cardiovasc Interv. 2013;82:64–73.CrossRefPubMed
48.
Kotowycz MA, Johnston KW, Ivanov J, et al. Predictors or Radial Artery Size in Patients Undergoing Cardiac Catheterization: Insights From the Good Radial Artery Size Predictions (GRASP) Study. Can J Cardiol. 2014;30:211–6.CrossRefPubMed
49.
Rathore S, Stables RH, Pauriah M, Hakeem A, Mills JD, Palmer ND, et al. Impact of length and hydrophilic coating of the introducer sheath on radial artery spasm during transradial coronary intervention: a randomized study. JACC Cardiovasc Interv. 2010;3(5):475–83.CrossRefPubMed
50.
Lefevre T, Thebault B, Spaulding C, Funck F, Chaveau M, Guillard N, et al. Radial artery patency after percutaneous left radial artery approach for coronary angiography: the role of heparin. Eur Heart J. 1995;16:293–7.
51.
Spaulding C, Lefevre T, Funck F, Thebault B, et al. Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn. 1996;39:365–70.CrossRefPubMed
52.
Pancholy SB. Comparison of the effect of intra-arterial versus intravenous heparin on radial artery occlusion after transradial catheterization. Am J Cardiol. 2009;104:1083–5.CrossRefPubMed
53.
Bernat I, Bertrand OF, Rokyta R, et al. Efficacy and Safety of Transient Ulnar Artery Compression to Recanalize Acute Radial Artery Occlusion After Transradial Catheterization. Am J Cardiol. 2011;107:1698–701.CrossRefPubMed
54.
Plante S, Cantor W, Goldman L, Miner S, Quesnelle A, Ganapathy A, et al. Comparison of Bivalirudin Versus Heparin on Radial Artery Occlusion After Transradial Catheterization. Catheter Cardiovasc Interv. 2010;76:654–8.CrossRefPubMed
55.
Feray H, Izgi C, Cetiner D, et al. Effectiveness of enoxaparin for prevention of radial artery occlusion after transradial cardiac catheterization. J Thromb Thrombolysis. 2010;29:322–5.CrossRefPubMed
56.•
Pancholy SB, Ahmed I, Bertrand OF, Patel T. Frequency of Radial Artery Occlusion After Transradial Access in Patients Receiving Warfarin Therapy and Undergoing Coronary Angiography. Am J Cardiol. 2014;113:211–4.CrossRefPubMed
57.
Pancholy SB, Coppola J, Patel T, Roke-Thomas M. Prevention of Radial Artery Occlusion-Patent Hemostasis Evaluation Trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv. 2008;72:335–40.CrossRefPubMed
58.
Cubero JM, Lombardo J, Pedrosa C, et al. Radial Compression Guided by Mean Artery Pressure Versus Standard Compression With a Pneumatic Device (RACOMAP). Catheter Cardiovasc Interv. 2009;73:467–72.CrossRefPubMed
59.
Pancholy SB. Transradial access in an occluded radial artery: new technique. J Invasive Cardiol. 2007;19:541–4.PubMed
60.•
Pasha AK, Elder MD, Malik UE, Khalid AM, Noor Z, Movahed MR. Symptomatic radial artery thrombosis successfully treated with endovascular approach via femoral access route. Cardiovasc Revasc Med. 2014;14:S1553–8389.
61.•
Jaradat Z, Basir B, Revtyak G. Treatment of Radial Artery Occlusions Using Balloon Angioplasty and Localized Intra-Arterial Abciximb. J Interv Cardiol. 2014;27:217–22.CrossRefPubMed
62.•
Rao SV, Tremmel JA, Gilchrist IC, Shah PB, et al. Best Practices for Transradial Angiography and Intervention: A Consensus Statement From the Society for Cardiovascular Angiography and Intervention’s Transradial Working Group. Catheter Cardiovasc Interv. 2014;83:228–36.CrossRefPubMed
Metadata
Title
Radial Artery Occlusion After Transradial Approach to Cardiac Catheterization
Authors
John F. Wagener
Sunil V. Rao
Publication date
01-03-2015
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 3/2015
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-015-0489-6

Other articles of this Issue 3/2015

Current Atherosclerosis Reports 3/2015 Go to the issue

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Role of Non-invasive Imaging in the Work-Up of Cardiomyopathies

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Available Transcatheter Aortic Valve Replacement Technology

Nonstatin Drugs (EM deGoma, Section Editor)

PCSK9 Inhibition: Current Concepts and Lessons from Human Genetics

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

The Role of Testosterone Therapy in Cardiovascular Mortality: Culprit or Innocent Bystander?

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Cardiovascular Prevention in the Cancer Survivor

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Use of Novel Antiplatelet Agents in Acute Coronary Syndromes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits